Strategic Pharmaceutical Patient Registry Program

 

Attention Pharmaceutical and Bio-Tech Professionals -- Be More Productive in 2007 by Leveraging a Proven, Cost-Effective & Strategic Patient Registry Program

Announcing ClinicalQuest, a powerful and cost effective tool for pharmaceutical and biotechnology professionals affording maximum productivity and effectiveness.

St. Louis / Atlanta (PRWeb) January 23, 2007 -- If you are a pharmaceutical or bio-technology professional, leveraging a patient registry system can help you with rapid clinical data capture, market research, treatment adherence and outcomes measurement.

Global Vision Technologies Inc (GVT) today announced the launch of ClinicalPursuit - a cost-effective; HIPAA compliant and rapid, clinical data capture software solution. Previously called "GVT's Patient Registry Program", ClinicalPursuit has all the benefits of the previous platform and more. "We're proud to launch ClinicalPursuit and based on the feedback we've been getting from our clients and partners, we feel it's a perfect addition to our line of proven pharmaceutical data collection and analysis tools and systems," says Chris Freund, President and CTO of GVT.

"ClinicalPursuit is just part of a bigger picture. Our Strategic Patient Registry Program (www.strategicpatientregistry.com) not only matches the right system to our client's specific objectives… our team of service professionals work with our clients from program development, to recruitment of Key Opinion Leaders (KOL's) and sites, to training, product launch, tracking and fulfillment and provide superior ongoing support and management throughout the process." said Freund.

Patient registries are nothing new, but when you can have a secure, customized solution that matches your exact initiatives… that won't break the bank - that is new. "The members at GVT are effective team builders. Rather than present a pre-packaged product, they offer a flexible solution that can be molded to the specific application and user group," says Dr. Paul Griggs, a Retina Specialist from Virginia Mason University and a present member of the program.

If you would like more information on how the Strategic Patient Registry Program can improve your bottom line in 2007 and beyond, please visit www.strategicpatientregistry.com and download their Special Report - "How to Leverage the Strategic Patient Registry Program to Improve Communication, Clinical Research, Relationships, Product Launches and Marketing Campaigns, in a Real-Time, Interactive Setting."

About Global Vision Technologies, Inc.
Global Vision Technologies was founded in 1994, and has since grown into a diverse provider of unique software applications that serve both public and private sector clients. The software services that GVT provides apply to four areas: Pharmaceutical Sales Operation & Patient Registry Applications, Elearning/Training and Development Certification systems (OmniTrackPlus), Sales, Marketing and CRM Applications and Case Management Systems for Human Services (FAMcare). GVT provides its clients with advanced web-based technologies that improve effectiveness and decision making, as well as increases productivity. For more information, visit us at www.globalvisiontech.com

###

Press Contact: G RITACCO
Company Name: Global Vision Technologies, Inc
Email: email protected from spam bots
Phone: 7708887872
Website: http://www.strategicpatientregistry.com

Prescription Drug Savings Statistics Report

 

Report Releases Prescription Drug Savings Statistics for Free Prescription Drug Card Holders

YourRxCard, provider of a free instant prescription drug discount card, has released its December claims report detailing user purchasing habits between generic and brand name prescription drugs. The report issued by www.YourRxCard.com reveals greater generic drug purchases by card holders, and over $46,994.13 savings to users in the month ending November 2005. The average user savings was 40% off of retail Pharmacy costs.

Baton Rouge, LA (PRWeb) January 22, 2007 -- YourRxCard (www.YourRxCard.com) has issued its December claims report on member savings, prescription drug purchasing habits, and predictions of future drug benefits and reach. YourRxCard is a Web-activated, free prescription drug card available to all Americans with no deductibles, pre-existing exclusions, or waiting periods to help with the increasing costs of prescription drugs. The card acts as a free repeat cash coupon on prescriptions.

Users of the free prescription drug card used 72.42% generic drugs and 27.58% brand name drugs in November, as opposed to most employer-provided prescription PBM benefit cards typically used for 25% generic drugs and 75% brand name drugs by members, according to YourRxCard's Chief Risk Officer, Rex Bowden Jr.

"(Month ending In November)… YourRxCard members saved $46,994.13 over the retail price of prescription drugs, and well over $150,000 since (YourRxCard went) live in July 2006," says Bowden. "YourRxCard predicts (that) as employers implement HSA, PCA, and HRA consumer/user benefit models, [consumers and employers will discover greater employer plan savings providing (the YourRxCard) free repeat cash coupon discount prescription drug card. Employers (will be able to) offer the benefits of YourRxCard to (their) employees, dependents, parents, and children for free. Which will result in saving millions of dollars through efficiency benefit cost gains. Everyone is eligible."

As a Web-based prescription drug discount solution, YourRxCard is working to build a strong brand online presence, to bring awareness of the drug card benefits to potential users. As a result of branding efforts, YourRxCard is very gratified that it can be found in multiple placements on page one of the top ten listings for search engines such as Google, AOL, Yahoo!, MSN, Webcrawler, Live, AllTheWeb, AltaVista, HotBox, and Ask.

The free prescription drug card is available to all Americans, including those currently on Medicare, to help with the rising costs of prescription drugs. YourRxCard's December claims report offers details on prescription drug claims and buy habits, based on statistics gathered in November 2006.

About YourRxCard.com
YourRxCard.com is a free prescription drug card program being produced to help all Americans cut their prescription drug costs. Individuals can download and print their free prescription drug card from www.YourRxCard.com, and receive savings of up to 75% at more than 50,000 national, regional, and local pharmacies. There are no deductibles, no waiting periods, and no pre-existing exclusions with the use of the card.

For more information about YourRxCard.com please visit www.YourRxCard.com, or contact Rex Bowden Jr. at 866-561-1926.

Contact:
Rex Bowden Jr.
YourRxCard
11608 Darryl Drive
Baton Rouge, LA 70815
Phone: 866-561-1926
Web: www.YourRxCard.com

###

Press Contact: REX BOWDEN
Company Name: YourRxCard
Email: email protected from spam bots
Phone: 866-561-1926
Website: http://www.yourrxcard.com

Red Fish To Get Interactive Lottery Data for Wireless Product Development

 

Gaming Solutions International to Supply my Red Fish with Interactive Lottery Data for Wireless Product Development

Gaming Solutions International's patent-pending interactive lottery data has been licensed to My Red Fish for wireless product development.

(PRWeb) January 22, 2007 -- Gaming Solutions International is pleased to announce their patent-pending interactive lottery data will be utilized by My Red Fish to develop interactive wireless lottery data applications for cell phones and mobile devices.

"Our interactive data modules are in great demand as they increase user satisfaction and revenues for our partners. We are pleased to be providing MyRedFish.com with our interactive lottery data module for use in their mobile applications," said John Brier, Managing Partner of Gaming Solutions International. "With 90 million lottery tickets played each week in the U.S. alone lottery data is in great demand every day. As more and more people begin relying on wireless devices to access news and information we are confident our patent-pending lottery data module will be a compliment to the My Red Fish product line."

MyRedFish.com is owned and operated by Red Fish Media. Red Fish Media offers some of the newest and quirkiest games, graphics, screensavers, wallpapers and applications available on the wireless market.

Gaming Solutions International offers multilingual interactive real-time lottery data covering over 200 U.S. based lottery games as well as full coverage of Canadian, UK, and German lottery games. Demonstrations of their interactive lottery data modules are available at www.LottoFactor.com

"In today's challenging online marketplace wireless companies are looking for ways to increase user satisfaction and also increase their ability to monetize mobile device applications. Our patent-pending lottery data module accomplish both of these tasks," added Brier.

About Gaming Solutions International:
Gaming Solutions International, LLC, is a Pensacola, FL, based technology company that produces patent-pending interactive lottery and horoscope results data for online and wireless media properties, to include newspapers, television stations, radio stations, portals, and news and information web sites. Lottery data coverage, available in English, Spanish, and French, includes all state and government sponsored lotteries in the United States, Canada, the U.K., and Ireland. Content partners include AOL, Bell South, AccuWeather, CBS Radio, Clear Channel Television, The Baltimore Sun, The Chicago Tribune, The Orlando Sentinel, MSNBC, MSN, Boston Herald, CBC New Media, ABC Television, NBC Television, CBS Television, Telemundo, Get Lisa, AT&T, and many others. For more information, visit their corporate web site at www.LottoFactor.com.

###

Press Contact: JOHN BRIER
Company Name: Gaming Solutions International, LLC
Email: email protected from spam bots
Phone: 850-292-2590
Website: www.LottoFactor.com

Protecting Intellectual Property & Regulatory Compliance

 

New Article on Protecting Intellectual Property & Regulatory Compliance Released

Cerulean Associates LLC (http://www.ceruleanllc.com/) is honored to announce the publication of its article on how biotechnology firms, pharmaceutical companies and research and development organizations can protect their intellectual property and achieve regulatory compliance during joint product development and drug discovery collaborations.

Williamsburg, VA (PRWeb) January 8, 2007 -- Cerulean Associates LLC announces its new article "Protecting Intellectual Property & Regulatory Compliance during Development Collaborations" published in the Winter edition of the European Biopharmaceutical Review.

Drawn upon its author's fifteen years in laboratory, preclinical and R&D environments, as well as his accountability as the CIO and head of an ISO-compliant records management department for a Fortune 50 medical device subsidiary, this article provides six practical steps to improve the retention of intellectual property. Following the recommendations within this article, biopharmaceuticals should be able to enhance the long-term security of their intellectual property. The techniques are adapted from regulatory compliance and information technology, and written to be seamlessly folded into already existent product development processes.

Lucy George, the Deputy Editor of the European Biopharmaceutical Review, said, "We heard about Cerulean's work with companies to build regulatory compliance into products and processes early on, and in review of their literature, saw how they understand and work within the different languages and cultures of compliance, information technology, R&D and legal."

"We approached Cerulean early in the autumn about writing an article for the executives of our readership. The result, written in plain, objective language, is really a "no-nonsense" primer on protecting your intellectual property while maintaining regulatory compliance."

Ms. George further noted, "The article, written by their Managing Director, John Avellanet, is straightforward, clear and full of realistic steps our readership can use today. It is definitely built upon years of experience and learning the hard way."

John Avellanet, the Managing Director of Cerulean, was thankful for the help of Ms. George and her team at Samedan Ltd. (the publisher of the European Biopharmaceutical Review), "Lucy and Neil and the rest of the Samedan team really provided a lot of insight to their audience. Writing down your experiences and knowledge so that it's straightforward and easily adapted by others can be a real challenge in the areas of intellectual property, regulatory compliance and R&D. All the options and advice from Lucy and team really helped shape the final article."

In addition to the published version in the Winter European Biopharmaceutical Review, Cerulean has made a downloadable PDF version of the article available on their website in their resource library.

The European Biopharmaceutical Review provides information for the pan-European biopharmaceutical market across Europe, North America & the rest of the developed world.

The European Biopharmaceutical Review (http://www.samedanltd.com/homepage/ebr.htm) is published quarterly and covers in-depth articles, case studies, meeting and report reviews written by specialists with "hands-on" experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies.

Established in 1997, the European Biopharmaceutical Review is distributed worldwide to more than 15,000 subscribers.

As a recognized leader, Cerulean Associates LLC blends Regulatory Compliance, IT advice and business expertise to bring preclinical R&D and product development organizations faster times to market and better financial results.

Cerulean (www.ceruleanllc.com) specializes in helping clients who need sophisticated advice, real results and the personal touch of a small firm. Clients achieve more innovation and a better bottom line. Complete confidentiality is part of every relationship.

Cerulean offers well-rounded, independent insights and help for all areas of IT and Compliance in the life sciences, pharmaceutical, medical device and biotechnology industries, including the contract organizations that support biopharmaceutical companies. Having worked extensively with R&D, IT, Quality and Legal, Cerulean is uniquely qualified to act as objective facilitators and advisors, ensuring mutual understanding and strategic agreement across your organization.

Find out more about Cerulean Associates, its resources, results and advisory services at http://www.ceruleanllc.com/

###

Press Contact: JOHN AVELLANET
Company Name: Cerulean Associates LLC
Email: email protected from spam bots
Phone: 757-645-2864
Website: http://www.ceruleanllc.com